SPRY2 and gastric adenocarcinoma: On the contrary, SPRY2 had significantly higher mRNA level in adjacent tissues compared with tumor or lymph node (Figure 3B), suggesting SPRY2 as a tumor suppressor in gastric adenocarcinoma.